In most overdose cases, morphine sulfate oral solutions ordered in milligrams were mistakenly swapped for milliliters of the product. Prior to the recent approval of the high potency 100 mg/5mL product, Roxane marketed a morphine sulfate moral solution with the strength expressed as 20 mg/mL.
The newly approved product labeling and packaging feature revisions intended to reduce the risk of medication errors, according to the report.
Read the ASA release on Roxane Laboratories.
Read more on the FDA:
–FDA Approves Opioid Analgesic for Breakthrough Cancer Pain
–7 GI/Endoscopy Devices Receive FDA Approval
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
